Brenntag Completes Acquisition of Esteemed Monarch Chemicals, Marking a Milestone in the Industry
Brenntag, a global leader in the distribution of chemicals and ingredients, has announced the acquisition of Monarch Group Holdings Ltd. And its U.K. subsidiary Monarch chemicals Ltd. This transaction marks a significant step for Brenntag in deepening its market position and expanding its range of services.
Commenting on the acquisition, Mr. Russel Argo, President of Brenntag Essentials Europe, Middle East and Africa, said: "The Monarch team has built a solid base of customers and supply partners with its superior products and services. We look forward to working with Monarch to drive the further development and expansion of this product line." With this transaction, Brenntag not only gains access to Monarch's expertise and infrastructure, but also strengthens our capabilities in the liquid and powder blending sector. With our acquisition strategy, we have been able to expand our last-mile services business and offer our customers a broader portfolio of products and value-added services supported by our global network. This expanded product line will benefit all our customers in the UK, bringing them even more choice and convenience."
Monarch Group Holdings Ltd., since its establishment in 1989, has been providing professional and reliable distribution services to the essential chemicals and blends markets across the UK. The company operates across several industrial segments and product groups, such as inorganic chemicals, citrate and glycol, and operates a number of plants and mixing facilities in the UK. With its operational excellence and market reach, Monarch achieved annual sales of £35.1 million in 2023.
Commenting on joining the Brenntag family, Monarch's Managing Director, Mr Jon Hill, said: "We are extremely proud of our ongoing commitment to providing exceptional service and support to our supply partners and customers. Our independence gives us the ability to respond flexibly to changes in the market, but joining Brenntag as a truly global distributor gives us additional scale advantages and network resources." We look forward to leveraging these strengths to drive the growth of our business and provide an even wider range and quality of services to our customers."
It is worth noting that although the financial details of the deal have not been made public, the signing and completion of the deal have been synchronized. This fully demonstrates the confidence and determination of both parties in this cooperation, and I believe that Brenntag and Monarch will work together to create even more brilliant results in the future.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
BASF Raises North American Nylon Products by $0.08/lb, Fourth Price Increase in Six Months
-
COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base
-
LyondellBasell Expands Laboratory Capabilities at Suzhou Technology Center
-
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
Recommend Reading
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
This week, sodium metabisulfite prices rose in China (4.20-4.24)
-
Cost Boost Limited; Adipic Acid Prices Continue to Decline in April
-
This Week, the Chinese Polymeric MDI Market Showed a Weak Decline (4.20-4.24)
-
Premium Global Chemical Sourcing Requests (24 - 28 Jan, 2026)
-
This Week, Anhydrous Hydrogen Fluoride Prices Remain Steady at High Levels in China (4.20-4.24)